Phase IV study on the use of benzydamine mouthwash in radiation-induced oral mucositis in patients with head and neck cancer.
Journal Information
Full Title: Front Oncol
Abbreviation: Front Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest VT, GDL, SF, ES, AC are full-time employees of Angelini Pharma S.p.A. PB received consulting fees from Angelini Pharma S.p.A. The authors declare that this study received funding from Angelini Pharma S.p.A. The funder had the following involvement in the study: study design, data collection and analysis, decision to publish, and preparation of the manuscript. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."
"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded by Angelini Pharma S.p.A."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025